federal income tax on gambling revenues
Financial Highlights * Third quarter total revenues were $283. 9 million * Generated net income of $42. 9 million or $0. 37 per diluted share * Total revenues increased 6. 4% for Nine Months 2007 to $893. 5 million vs. Nine Months 2006 * Cash and short- and long-term investments grew to $932. 3 million * Anticipated 2008 fully diluted earnings per share range of approximately $2. 35-$2. 45 per share Other Operational Highlights * Established partnerships for development and commercialization of eszopiclone with Eisai Co. Ltd.for Japan and GlaxoSmithKline for all markets outside of North America and Japan Most Popular Anniversary Performance Review Form 8 Keys To Designing A Sales Comp Plan That Delivers Request To Beat Competitor's Price Time Management: Stop Procrastination Today Productivity Benchmarks And the Process of Benchmarking * Planned reduction in sales and marketing expenses of approximately $90-$100 million for 2008, including an anticipated reduction of approximately 300 sales force positions MARLBOROUGH, Mass.-- Sepracor Inc.(Nasdaq: SEPR) today announced its consolidated financial results for the third quarter and nine months ended September 30, 2007. online casino poker gambling casino free games bonus accepts winning the jackpot online slots top dollar game
